移动应用程序干预对药物坚持和2型糖尿病控制的影响:系统审查和元分析
Cheng Jun Chong1, Mohd Makmor Bakry1, Ernieda Hatah1
1Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Journal of telemedicine and telecare
|May 31, 2023
概括
移动应用程序可以改善药物服药和控制2型糖尿病. 这次审查发现,在应用程序使用时,HbA1c和禁食血葡萄糖的显著降低.
科学领域:
- 医疗信息学 医疗信息学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 人们普遍不坚持抗糖尿病治疗,这阻碍了治疗疗效和疾病管理.
- 这导致治疗结果低于最佳,疾病进展至并发症.
- 移动应用程序 (APP) 提供了一种潜在的干预措施,以改善药物坚持和2型糖尿病 (T2DM) 控制.
研究的目的:
- 系统地审查和元分析移动应用程序干预措施对药物坚持的影响.
- 评估移动应用程序对T2DM患者血糖控制的影响.
主要方法:
- 按照PRISMA指南进行的系统审查和元分析.
- 搜索的数据库:科学网,PubMed,斯科普斯,科克兰图书馆,奥维德 (2017-2022年).
- 提取和定量分析研究特征,坚持状态和血糖控制结果.
主要成果:
- 包括8项研究,884名参与者;方法质量各不相同.
- 三项研究表明,随着移动应用程序的使用,药物服药能力在统计学上显著改善.
- 与非应用程序用户相比,移动应用程序显著降低了HbA1c的0.36%和FPG的16.75 mg/dL.
结论:
- 移动应用程序干预表明对T2DM的药物坚持和血糖控制产生积极影响.
- 需要进一步的研究来确定这些干预措施的最佳现实世界实施策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
Carbohydrate Metabolism
11.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K
Insulin: Dosing Regimen and Adverse Effects
217
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
217


